0001736945-18-000006.txt : 20180530
0001736945-18-000006.hdr.sgml : 20180530
20180530145303
ACCESSION NUMBER: 0001736945-18-000006
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20180530
DATE AS OF CHANGE: 20180530
EFFECTIVENESS DATE: 20180530
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Cidara Therapeutics, Inc.
CENTRAL INDEX KEY: 0001610618
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 461537286
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-313514
FILM NUMBER: 18867751
BUSINESS ADDRESS:
STREET 1: 6310 NANCY RIDGE DRIVE
STREET 2: SUITE 101
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 858-752-6170
MAIL ADDRESS:
STREET 1: 6310 NANCY RIDGE DRIVE
STREET 2: SUITE 101
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
FORMER COMPANY:
FORMER CONFORMED NAME: K2 THERAPEUTICS, INC.
DATE OF NAME CHANGE: 20140611
D
1
primary_doc.xml
X0708
D
LIVE
0001610618
Cidara Therapeutics, Inc.
6310 NANCY RIDGE DRIVE
SUITE 101
SAN DIEGO
CA
CALIFORNIA
92121
858-752-6170
DELAWARE
K2 THERAPEUTICS, INC.
Corporation
true
Jeffrey
Stein
c/o Cidara Therapeutics, Inc.
6310 Nancy Ridge Dr
San Diego
CA
CALIFORNIA
92121
Executive Officer
Director
Daniel
D
Burgess
c/o Cidara Therapeutics, Inc.
6310 Nancy Ridge Dr
San Diego
CA
CALIFORNIA
92121
Director
Scott
M
Rocklage
c/o Cidara Therapeutics, Inc.
6310 Nancy Ridge Dr
San Diego
CA
CALIFORNIA
92121
Director
Theodore
R
Schroeder
c/o Cidara Therapeutics, Inc.
6310 Nancy Ridge Dr
San Diego
CA
CALIFORNIA
92121
Director
Robert
J
Perez
c/o Cidara Therapeutics, Inc.
6310 Nancy Ridge Dr
San Diego
CA
CALIFORNIA
92121
Director
Timothy
R
Franson
c/o Cidara Therapeutics, Inc.
6310 Nancy Ridge Dr
San Diego
CA
CALIFORNIA
92121
Director
Matthew
Onaitis
c/o CidaraTherapeutics, Inc.
6310 Nancy Ridge Dr
San Diego
CA
CALIFORNIA
92121
Executive Officer
Taylor
Sandison
c/o CidaraTherapeutics, Inc.
6310 Nancy Ridge Dr
San Diego
CA
CALIFORNIA
92121
Executive Officer
Chrysa
Mineo
c/o CidaraTherapeutics, Inc.
6310 Nancy Ridge Dr
San Diego
CA
CALIFORNIA
92121
Director
Biotechnology
Decline to Disclose
- 06b
false
2018-05-23
true
true
true
false
0
1874999
1562499
312500
Represents warrants to purchase shares of Common Stock; such warrants have not yet been exercised.
false
16
1950000
0
Sales Commission amount also covered the $120.0 million concurrent registered direct offering. The Issuer has also agreed to reimburse the placement agents for certain of their expenses related to the offering in an amount up to $40,000.
0
false
Cidara Therapeutics, Inc.
/s/ Matthew Onaitis
Matthew Onaitis
Chief Financial Officer
2018-05-29